WebenPharma
PrivateLast Round
Angel
Jan 28, 2022
Company Overview
WebenPharma is a biopharmaceutical company that focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WebenPharma Comparables
Compare WebenPharma with similar companies based on industry and business-model similarity.
WebenPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 28, 2022 | ||||
| Angel | Jan 28, 2019 |
WebenPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tailong Investment | Angel |
| Tigeryeah Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2019
Completed an angel funding round.
WebenPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WebenPharma's valuation, stock price, and market status.
Is WebenPharma a public or private company?
WebenPharma is a private company.
What is the current stock price of WebenPharma?
WebenPharma is a private company with no public stock price. Caplight tracks WebenPharma's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is WebenPharma worth (valuation)?
Valuation information for WebenPharma is not publicly available.
Can I buy WebenPharma stock?
WebenPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was WebenPharma's last funding round?
WebenPharma's most recent funding round was Angel on January 28, 2022.
Who are the main investors in WebenPharma?
Key investors in WebenPharma include Tailong Investment, Tigeryeah Capital.
Will WebenPharma IPO soon?
No public IPO plans have been announced for WebenPharma.
How can I track WebenPharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WebenPharma's secondary market activity and sign up for updates.